4
Changes in Ownership
Monte Rosa Therapeutics, Inc. Filed Acc 0001193125-26-307791
President & CEO sold 9,500 shares at $23.18 ($220,219)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Warmuth Markus President & CEO | 2026-07-16 | Sale | −9,500 | $23.18 | $220,219 | 585,038 | D: show line 1 in the form |
| Open-market sales · 9,500 sh · avg $23.18 · $220,219 | |||||||
Loading xslF345X06/ownership.xml…